1 Peer review. All manuscripts sent for publication in Biotechnology Bulletin are strictly and thoroughly peer-reviewed, and the peer review process is double-blind. Our editorial office first reviews the submitted manuscript whether it conforms to the publication scope of Biotechnology Bulletin. The manuscript that has passed the preliminary review will be submitted to the managing editor in editorial office, who will review again whether the manuscript conforms to the publication scope and whether the content is innovative and valuable. Then, the managing editor will send the manuscripts that have passed the review to two reviewers for peer review. The managing editor will track the review progress of the manuscript, collect at least two review comments, and submit them to the deputy chief editor, who will review whether the manuscript is accepted or not. Before submitting to the deputy chief editor for approval, the author is required to make sufficient modifications (peer review again if necessary). The deputy chief editor shall check and decide whether the manuscript is accepted according to the review comments, and then submit the manuscript to the chief editor for final review. Regardless of whether a paper is accepted or rejected, the editorial office will inform the author of the evaluation results.
2 Originality. By submitting your manuscript to Biotechnology Bulletin, it is understood that this is an original manuscript and is unpublished work and is not under consideration elsewhere. Plagiarism, including duplicate publication of the author’s own work, in whole or in part without proper citation is not tolerated by the journal. Manuscripts submitted to Biotechnology Bulletin may be checked for originality using anti-plagiarism software (CNKI- Academic Misconduct Document Detection System for Science and Technology Journals (AMLC)).
3 Open Access. All articles published by Biotechnology Bulletin are available online for free under a Creative Commons CC BY-NC-ND copyright agreement. The journal is supported by Article Processing Charge (APC). The specific standard is as follows: 460 yuan/page. Details about CC BY-NC-ND can be found at https://creativecommons.org/licenses/by-nc-nd/4.0/.
4 Copyright and Licensing. Copyright on any article in Biotechnology Bulletin retained by the author(s) under the Creative Commons License. Authors and third-parties have right to share the articles (such as stored in institutional repositories), or use it for other academic (non-commercial) purposes under the CC BY-NC-ND (Attribution-NonCommercial-NoDerivatives) 4.0 license.
The copyright owner allows others to copy, distribute, exhibit, perform, show, broadcast, or disseminate their published articles to the public through internet. However, during these processes, the other party must give proper credit to authors. The above use are limited to non-commercial purposes and cannot be used for deductive creation.
5 Open Access Policy. Biotechnology Bulletin is an open access journal: All articles will be immediately and permanently free on the official website (https://biotech.aiijournal.com/), allowing anyone to read and download as long as published.
Permitted third party reuse is defined by the following user license: Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND). The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.
In addition to archiving on the official website, the journal also supports the sponsors to store the full-text data of the journal into the institutional knowledge base (i.e., National Agricultural Library). The journal encourages and supports the author or the author’s institute to store the author’s published articles in this journal, immediately after publication, in the institutional knowledge base or the author's personal website to implement self-storage. The stored version is the final published one after peer review in a way of CC-BY-NC-ND. However, the standard journal publication information should be indicated in the institutional knowledge base metadata and used as a recommended reference method.
6 Conflicts of interest. Biotechnology Bulletin’s policy requires that each author reveals any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition. In addition, financial competing interests, such as awards, pending patents, and ownership of stock shares/options, along with non-financial competing interests, such as advisory board members, related consulting services, and personal relationships, are also required to be disclosed by authors.
7 Disclaimer. The opinions expressed in Biotechnology Bulletin are those of the authors and contributors, and do not necessarily reflect those of the editors, the editorial board, or the organization to which the authors are affiliated.
8 Advertising Statement. The journal does not publish any commercial advertisements. All articles and the official website are free of advertising content. Editorial decisions on manuscript review or acceptance are not influenced by any commercial factors.
